Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor

MLA

Suzanne M. Cutts, et al. “Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor.” PLoS ONE, vol. 7, no. 2, Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....42885806daa5121f10359910712845f5&authtype=sso&custid=ns315887.

APA

Suzanne M. Cutts, Nataly Tarasenko, Ada-D.-A. Rephaeli, Aida Inbal, Gania Kessler-Icekson, Abraham Nudelman, & Don R. Phillips. (2012). Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor. PLoS ONE, 7(2).

Chicago

Suzanne M. Cutts, Nataly Tarasenko, Ada-D.-A. Rephaeli, Aida Inbal, Gania Kessler-Icekson, Abraham Nudelman, and Don R. Phillips. 2012. “Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor.” PLoS ONE 7 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....42885806daa5121f10359910712845f5&authtype=sso&custid=ns315887.